Arkolith/Insider Trading/ELV/Form 4

Boudreaux Gail

President and CEO, DirectorElevance Health, Inc. (ELV) · full profile →Form 4 · filed Jul 17, 2026
Net Buying
Open-Market Buys
$1.0M
Open-Market Sells
$0
Net Open-Market Flow
$1.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 17, 2026Buy(P)680$366.41$249K170K
Jul 17, 2026Buy(P)2K$368.25$753K172K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001287920-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML